Crossmark

Plasma Lipid Profiling Identifies Phosphatidylcholine 34:3 and Triglyceride 52:3 as Potential Markers Associated with Disease Severity and Oxidative Status in Chronic Obstructive Pulmonary Disease

Crossref DOI link: https://doi.org/10.1007/s00408-022-00552-z

Published Online: 2022-07-11

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ben Anes, Amel https://orcid.org/0000-0003-0030-3442
Ben Nasr, Hela

Tabka, Zouhair

Tabka, Oussama

Zaouali, Monia

Chahed, Karim
Funding

Funding for this research was provided by:

the Tunisian Ministry of Higher Education and Research (LR19ES09). (LR19ES09, LR19ES09, LR19ES09, LR19ES09, LR19ES09, LR19ES09)
License Information

Text and Data Mining valid from 2022-07-11

Version of Record valid from 2022-07-11
More Information

Article History

Received: 29 April 2022

Accepted: 20 June 2022

First Online: 11 July 2022

Declarations

:

: The authors declare that they have no conflict of interests.

: The study protocol was approved by the ethics committee of “Farhat Hachad” Hospital (Approval number: 08-2011, Sousse, Tunisia).

: Informed consent was obtained from all individual participants included in the study<i>.</i>

: None.

Document is current

Any future updates will be listed below